drugset / Trial / NCT03771560

Folinic Acid in Autism

NCT03771560

Phase 2/3 Completed 18 enrolled University of California, San Francisco
NaSingle-groupOpen-labelTreatment

Summary

An examination of changes in urinary metabolites with use of folinic acid in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures and academic measures monthly at school with teachers and parents report.

Timeline

Start
2018-02-15
Primary completion
2018-06-30
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule